Theriva Biologics, Inc. (AMEX: TOVX) last traded at $0.216, down 1.69% on the session. The quote above updates while this page is open; the figures below are drawn from Theriva Biologics, Inc.’s own filings and are restated only when a new one is published.
Theriva Biologics, Inc. trades on AMEX under the ticker TOVX. Its market capitalisation is $9.90 million.
Valuation measures for Theriva Biologics, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $9.90M |
|---|---|
| Enterprise value | $21.23M |
| Price / book | 0.81 |
| Beta | 3.07 |
Trailing-twelve-month figures tagged in Theriva Biologics, Inc.'s XBRL filings with the SEC.
| Net income (TTM) | -$11.62M |
|---|
| Return on equity | -95.33% |
|---|
| Cash | $11.34M |
|---|
Range and volume for TOVX over the past 52 weeks.
| 52-week high | $0.860 |
|---|---|
| 52-week low | $0.160 |
| Volume | 360.0K |
| Average volume | 530.0K |
| Previous close | $0.219 |
Invest a chosen dollar amount in Theriva Biologics, Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell TOVX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.